PPBT
Purple Biotech
PPBT
PPBT
14 hedge funds and large institutions have $378K invested in Purple Biotech in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
60% less capital invested
Capital invested by funds: $946K → $378K (-$568K)
79% less call options, than puts
Call options by funds: $35K | Put options by funds: $167K
Holders
14
Holding in Top 10
–
Calls
$35K
Puts
$167K
Top Buyers
| 1 | +$129K | |
| 2 | +$59.2K | |
| 3 | +$41.5K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$32.9K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$6.54K |
Top Sellers
| 1 | -$877K | |
| 2 | -$11.3K | |
| 3 | -$234 | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$108 |